RNVS Says Saint I Phase III Trial Demonstrated a Statistically Significant Reduction in Disability
Tweet Send to a Friend
Renovis, Inc. (Nasdaq: RNVS) announced today that a first analysis of data from the Phase III SAINT I trial involving ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
